IMC Chicago’s Bio-Techne TECH Stock Holding History

IMC Chicago’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.03M	Sell	14,600 -14,400	-50%	-$778K	﹤0.01%	3824
2026 Q1	$1.52M	Buy	29,000 +4,700	+19%	+$282K	﹤0.01%	2849
2025 Q4	$1.43M	Buy	+24,300	New	+$1.48M	﹤0.01%	2696

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

IMC Chicago's TECH Position: Q2 2026 in Review

IMC Chicago sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 5,160 shares — an estimated $279K sold.

IMC Chicago first reported a position in TECH in Q4 2025 and held it in 2 quarters. The position peaked at $906K in Q4 2025. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

IMC Chicago reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
IMC Chicago sold 5,160 Bio-Techne shares in Q2 2026, an estimated $279K.
IMC Chicago first reported a position in Bio-Techne in Q4 2025 and held it in 2 quarters.
IMC Chicago's Bio-Techne position peaked at $906K in Q4 2025.
596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.